argenx SE Investor Day Presentation Deck slide image

argenx SE Investor Day Presentation Deck

Our Pipeline Starts with our Immunology Innovation Program CLINICAL DEVELOPMENT S argenx ANTIBODY ENGINEERING argenx Internal Value Creation First in Class | Unique Design | Multiple Indications Efgartigimod ARGX-117 ARGX-119 ARGX-118 Cusatuzumab LEADING TRANSLATIONAL BIOLOGY LABS External Value Creation Staten (ARGX-116) Genor (ARGX-109) AgoMAb (ARGX-114) LEO (ARGX-112) Dualyx AbbVie (ARGX-115) 12
View entire presentation